Actionable Insights from Curated Molecular Interactions - Practical Use Cases

Live Webinar July 8th, 10 a.m. ET/ 4 p.m. CET
Biomedical research relies on the ability to contextualize experimental data in biological contexts. While high throughput technologies generate vast amounts of omics data, deriving actionable insight requires trusted, well structured knowledge of molecular mechanisms, regulatory relationships, and disease associations. 

To that end, on this webinar we will cover reproducible, programmatic workflows that support key discovery and translational use cases leveraging a manually curated molecular interaction database, containing over 5 million high quality, directional, and evidence annotated interactions between proteins, complexes, RNAs and small molecules. Use cases will include:
 
  • Mechanism of action reconstruction
  • Biomarker characterization
  • Target assessment
  • Biological interpretation of omics data

Attendees will gain a practical understanding of how molecular interaction knowledge can be integrated into AI-powered analysis pipelines and enabling transparent and explainable insights that go beyond black box analytics.
 

Join us to learn more

HIDDEN FIELDS BELOW

“Lorem ipsum dolor sit amet. Cum magnam modi sit voluptatem dolores et architecto unde ex ipsum labore eos asperiores cupiditate et dignissimos modi ut fugit optio.”

Qui incidunt, impedit ab animi quam et itaque aliquid et quasi perspiciatis

“Lorem ipsum dolor sit amet. Cum magnam modi sit voluptatem dolores et architecto unde ex ipsum labore eos asperiores cupiditate et dignissimos modi ut fugit optio.”

Qui incidunt, impedit ab animi quam et itaque aliquid et quasi perspiciatis

“Lorem ipsum dolor sit amet. Cum magnam modi sit voluptatem dolores et architecto unde ex ipsum labore eos asperiores cupiditate et dignissimos modi ut fugit optio.”

Qui incidunt, impedit ab animi quam et itaque aliquid et quasi perspiciatis

Moderator

Matt Wampole, Director, Solution Consulting

Matt Wampole is the Director of Solution Consulting at Clarivate where he and his team support clients from discovery to launch of new medical interventions. His 20 years of experience have covered a broad range of topics across drug discovery and optimization, clinical trial optimization, regulatory intelligence, and business development. What excites him the most is how unifying disparate datasets with new technologies like AI/ML and GenAI will lead to new treatments for unmet medical needs.

Expert Speaker - Alex Ishkin, Lead Consultant, Discovery and Translational Science, Clarivate

Alex Ishkin is a lead consultant with 20 years of experience in bioinformatics, software development and system biology. He is an expert in MetaBase and creator of the metabaser R package for MetaBase knowledge retrieval and analytics. Alex is also lead of two Clarivate-led consortia devoted to bioinformatics tool implementation (CBDD) and benchmarking (ABC)

Expert Speaker - Marti Bernardo-Faura, Manager, Discovery and Translational Science, Clarivate

Martí is a computational systems biologist with 18 years of experience applying network biology to understand complex disease mechanisms. He has developed integrative models combining multi-omics data to support therapeutic strategy design, biomarker identification and indication prioritization across diseases including cancer and multiple sclerosis. He is currently a senior consultant in Discovery and Translational Sciences, where he applies quantitative approaches to translate complex biological data into actionable insights.